Here are relevant reports on : workflow-automation-market
-
Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030
The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030
The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031
The UK next-generation sequencing market, valued at USD 0.73 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 14.8% from 2026 to 2031, culminating in a forecasted valuation of USD 1.59 billion by the end of the period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029
The global protein expression market, valued at US$3.34 billion in 2023, stood at US$3.41 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$4.82 billion by the end of the period. This growth is driven by the increasing demand for biologics, rising R&D investments in the pharmaceutical and biopharmaceutical sectors, and the growing use of artificial intelligence and machine learning to improve protein structure and function predictions.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Workflow Orchestration Market by Type (Cloud Orchestration, Data Center Orchestration, Business Process Orchestration, and Security Orchestration), Organization Size (SMEs and Large Enterprises), Vertical, and Region - Global Forecast to 2022
The workflow orchestration market is projected to grow from USD 13.81 Billion in 2017 to USD 50.82 Billion by 2022, at a CAGR of 29.8% during the forecast period. The adoption of workflow orchestration by organizations to improve operational efficiency, productivity levels, and business outcomes is one of the most significant factors projected to drive the growth of the workflow orchestration market. Digital transformation of organizations and the need to streamline business processes will offer lucrative growth opportunities to workflow orchestration providers in the near future. Key players operating in the workflow orchestration market include Microsoft (US), IBM (US), Cisco Systems (US), Oracle (US), VMware (US), CA Technologies (US), Arvato AG (Germany), BMC Software (US), ServiceNow (US), Micro Focus (UK), Dalet SA (France), and Ayehu Software Technologies (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030
The global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
The next-generation sequencing market, valued at USD 13.95 billion in 2024, stood at USD 14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of USD 29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The Europe Next-generation Sequencing Market, valued at US$4.11 billion in 2024, stood at US$4.42 billion in 2025 and is projected to advance at a resilient CAGR of 15.0% from 2025 to 2030, culminating in a forecasted valuation of US$8.88 billion by the end of the period. The Europe next-generation sequencing market is expanding on the back of accelerating use of sequencing across oncology, rare disease diagnostics, and broader precision medicine programs, supported by robust public and private research funding
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Cloud Enterprise Content Management Market by Solution (Document Management, Case Management, Workflow Management, Record Management, and E-Discovery), Service, Deployment Model, Organization Size, Vertical, and Region - Global Forecast to 2022
The cloud Enterprise Content Management (ECM) market size is expected to grow from USD 9.77 Billion in 2017 to USD 34.42 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 28.6%. The major drivers of this market include the growth in the digital content across enterprises, easier access from remote end-points, need for protection of enterprise data against the disaster, and need for regulatory compliances.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
China Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The China Next-Generation Sequencing market, valued at USD 1.23 billion in 2025, stood at USD 1.35 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 2.84 billion by the end of the period. Next-generation sequencing refers to advanced DNA and RNA sequencing technologies that enable rapid, high-throughput analysis of genetic material.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
